Exercise improves clinical symptoms, quality of life, global functioning, and depression in schizophrenia: a systematic review and meta-analysis

M Dauwan, MJH Begemann, SM Heringa… - Schizophrenia …, 2016 - academic.oup.com
Background: Physical exercise may be valuable for patients with schizophrenia spectrum
disorders as it may have beneficial effect on clinical symptoms, quality of life and cognition …

Why not try harder? Computational approach to motivation deficits in neuro-psychiatric diseases

M Pessiglione, F Vinckier, S Bouret, J Daunizeau… - Brain, 2018 - academic.oup.com
Motivation deficits, such as apathy, are pervasive in both neurological and psychiatric
diseases. Even when they are not the core symptom, they reduce quality of life, compromise …

The current conceptualization of negative symptoms in schizophrenia

SR Marder, S Galderisi - World Psychiatry, 2017 - Wiley Online Library
Negative symptoms have long been conceptualized as a core aspect of schizophrenia. They
play a key role in the functional outcome of the disorder, and their management represents a …

Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis

B Helfer, MT Samara, M Huhn, E Klupp… - American Journal of …, 2016 - Am Psychiatric Assoc
Objective: The authors examined the safety and efficacy of antidepressants added to
antipsychotic drugs in the treatment of schizophrenia. Method: Multiple databases and …

Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders–A comprehensive systematic review and meta-analysis

R Jeppesen, RHB Christensen, EMJ Pedersen… - Brain, behavior, and …, 2020 - Elsevier
Objective Antipsychotic effects of immunomodulating drugs have been suggested; however,
a thorough, comprehensive meta-analysis on the effect and safety of anti-inflammatory add …

Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia

M Carbon, CU Correll - CNS spectrums, 2014 - cambridge.org
Since currently available antipsychotic medications predominantly treat hallucinations,
delusions, disorganized thoughts and behavior, and related agitation/aggression, attention …

Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome

G Fervaha, G Foussias, O Agid, G Remington - Schizophrenia research, 2015 - Elsevier
Negative symptoms, in particular motivational deficits, are reported as impediments to
functional recovery in patients with schizophrenia. This study examined the prevalence of …

Duration of untreated illness as a key to early intervention in schizophrenia: a review

A Murru, B Carpiniello - Neuroscience letters, 2018 - Elsevier
The first psychotic episode is classically viewed as a critical period which management is
important in determining the long-term outcome of the schizophrenia (SCZ). For this reason …

The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors

W Fleischhacker, S Galderisi, I Laszlovszky… - European …, 2019 - cambridge.org
Background: Negative symptoms in schizophrenia are heterogeneous and
multidimensional; effective treatments are lacking. Cariprazine, a dopamine D3-preferring …

Improving pleasure and motivation in schizophrenia: a randomized controlled clinical trial

J Favrod, A Nguyen, J Chaix, J Pellet… - Psychotherapy and …, 2019 - karger.com
Background: Negative symptoms are frequent in patients with schizophrenia and are
associated with marked impairments in social functioning. The efficacy of drug-based …